US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 25.680
  • -0.060-0.23%
Trading Mar 25 14:24 ET
3.12BMarket Cap19.60P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
23.49%491.73M
28.26%141.82M
25.33%128.7M
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
Operating revenue
23.49%491.73M
28.26%141.82M
25.33%128.7M
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
Cost of revenue
32.48%68.85M
36.90%21.64M
36.07%19.28M
27.90%15.41M
25.88%12.52M
51.10%51.97M
41.21%15.81M
46.58%14.17M
57.60%12.05M
68.86%9.95M
Gross profit
22.14%422.89M
26.82%120.18M
23.61%109.42M
22.58%107.31M
14.01%85.99M
92.56%346.24M
91.19%94.76M
86.05%88.52M
92.52%87.54M
102.75%75.42M
Operating expense
-12.20%227.77M
8.04%57.33M
-53.46%58.51M
29.93%53.06M
47.86%58.86M
232.72%259.43M
182.86%53.07M
459.28%125.71M
141.63%40.84M
100.73%39.81M
Selling and administrative expenses
32.93%177.74M
5.13%44.19M
36.71%45.88M
43.44%40.73M
57.94%46.94M
134.23%133.71M
198.38%42.04M
145.88%33.56M
119.82%28.4M
80.88%29.72M
-Selling and marketing expense
28.44%111.34M
6.01%30.67M
34.24%29.11M
43.33%26.25M
42.54%25.32M
--86.69M
--28.93M
185.88%21.68M
151.95%18.31M
161.62%17.76M
-General and administrative expense
41.20%66.4M
3.18%13.52M
41.22%16.78M
43.62%14.48M
80.83%21.62M
--47.02M
--13.1M
95.86%11.88M
78.48%10.08M
24.00%11.95M
Research and development costs
-86.42%12.65M
92.60%3.8M
-96.07%3.28M
-24.51%2.99M
-27.54%2.58M
370.72%93.15M
-51.82%1.97M
906.76%83.66M
-0.73%3.95M
4.67%3.56M
Depreciation amortization depletion
14.78%37.38M
3.15%9.34M
10.11%9.35M
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
-Depreciation and amortization
14.78%37.38M
3.15%9.34M
10.11%9.35M
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
Operating profit
124.77%195.12M
50.73%62.84M
236.90%50.91M
16.16%54.25M
-23.82%27.13M
-14.75%86.81M
35.36%41.69M
-248.15%-37.19M
63.46%46.7M
105.05%35.61M
Net non-operating interest income expense
243.61%16.06M
224.39%4.62M
1,812.08%4.54M
109.82%3.8M
4.68M
1.42M
-265K
1.81M
Total other finance cost
-243.61%-16.06M
-224.39%-4.62M
-1,812.08%-4.54M
-109.82%-3.8M
----
---4.68M
---1.42M
--265K
---1.81M
----
Other net income (expense)
67.82%5.08M
87.14%6.72M
409.68%1.76M
-2.26M
15.20%1.96M
4.96%3.02M
62.75%3.59M
-162.76%-568K
1,732.26%1.7M
Gain on sale of security
67.82%5.08M
87.14%6.72M
409.68%1.76M
---2.26M
----
--3.02M
--3.59M
---568K
----
----
Other non- operating income (expenses)
----
----
----
----
15.20%1.96M
----
----
----
----
1,732.26%1.7M
Income before tax
128.82%216.26M
58.82%74.18M
250.46%57.21M
15.00%55.79M
-22.04%29.09M
-9.75%94.51M
41.50%46.71M
-246.20%-38.02M
71.75%48.51M
113.72%37.31M
Income tax
126.72%52.37M
53.80%18.25M
283.56%13.32M
39.48%14.99M
-24.93%5.81M
6.75%23.1M
57.40%11.86M
-322.68%-7.26M
62.24%10.75M
83.62%7.75M
Net income
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
Net income continuous Operations
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
Minority interest income
Net income attributable to the parent company
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
129.50%163.89M
60.53%55.94M
242.65%43.88M
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
Basic earnings per share
105.97%1.38
42.42%0.47
227.59%0.37
-2.78%0.35
-28.57%0.2
-16.25%0.67
37.50%0.33
-231.82%-0.29
71.43%0.36
115.38%0.28
Diluted earnings per share
107.94%1.31
41.94%0.44
220.69%0.35
0.00%0.33
-26.92%0.19
-16.00%0.63
40.91%0.31
-245.00%-0.29
65.00%0.33
116.67%0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 23.49%491.73M28.26%141.82M25.33%128.7M23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M
Operating revenue 23.49%491.73M28.26%141.82M25.33%128.7M23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M
Cost of revenue 32.48%68.85M36.90%21.64M36.07%19.28M27.90%15.41M25.88%12.52M51.10%51.97M41.21%15.81M46.58%14.17M57.60%12.05M68.86%9.95M
Gross profit 22.14%422.89M26.82%120.18M23.61%109.42M22.58%107.31M14.01%85.99M92.56%346.24M91.19%94.76M86.05%88.52M92.52%87.54M102.75%75.42M
Operating expense -12.20%227.77M8.04%57.33M-53.46%58.51M29.93%53.06M47.86%58.86M232.72%259.43M182.86%53.07M459.28%125.71M141.63%40.84M100.73%39.81M
Selling and administrative expenses 32.93%177.74M5.13%44.19M36.71%45.88M43.44%40.73M57.94%46.94M134.23%133.71M198.38%42.04M145.88%33.56M119.82%28.4M80.88%29.72M
-Selling and marketing expense 28.44%111.34M6.01%30.67M34.24%29.11M43.33%26.25M42.54%25.32M--86.69M--28.93M185.88%21.68M151.95%18.31M161.62%17.76M
-General and administrative expense 41.20%66.4M3.18%13.52M41.22%16.78M43.62%14.48M80.83%21.62M--47.02M--13.1M95.86%11.88M78.48%10.08M24.00%11.95M
Research and development costs -86.42%12.65M92.60%3.8M-96.07%3.28M-24.51%2.99M-27.54%2.58M370.72%93.15M-51.82%1.97M906.76%83.66M-0.73%3.95M4.67%3.56M
Depreciation amortization depletion 14.78%37.38M3.15%9.34M10.11%9.35M10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M
-Depreciation and amortization 14.78%37.38M3.15%9.34M10.11%9.35M10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M
Operating profit 124.77%195.12M50.73%62.84M236.90%50.91M16.16%54.25M-23.82%27.13M-14.75%86.81M35.36%41.69M-248.15%-37.19M63.46%46.7M105.05%35.61M
Net non-operating interest income expense 243.61%16.06M224.39%4.62M1,812.08%4.54M109.82%3.8M4.68M1.42M-265K1.81M
Total other finance cost -243.61%-16.06M-224.39%-4.62M-1,812.08%-4.54M-109.82%-3.8M-------4.68M---1.42M--265K---1.81M----
Other net income (expense) 67.82%5.08M87.14%6.72M409.68%1.76M-2.26M15.20%1.96M4.96%3.02M62.75%3.59M-162.76%-568K1,732.26%1.7M
Gain on sale of security 67.82%5.08M87.14%6.72M409.68%1.76M---2.26M------3.02M--3.59M---568K--------
Other non- operating income (expenses) ----------------15.20%1.96M----------------1,732.26%1.7M
Income before tax 128.82%216.26M58.82%74.18M250.46%57.21M15.00%55.79M-22.04%29.09M-9.75%94.51M41.50%46.71M-246.20%-38.02M71.75%48.51M113.72%37.31M
Income tax 126.72%52.37M53.80%18.25M283.56%13.32M39.48%14.99M-24.93%5.81M6.75%23.1M57.40%11.86M-322.68%-7.26M62.24%10.75M83.62%7.75M
Net income 129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M
Net income continuous Operations 129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M
Minority interest income
Net income attributable to the parent company 129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 129.50%163.89M60.53%55.94M242.65%43.88M8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M
Basic earnings per share 105.97%1.3842.42%0.47227.59%0.37-2.78%0.35-28.57%0.2-16.25%0.6737.50%0.33-231.82%-0.2971.43%0.36115.38%0.28
Diluted earnings per share 107.94%1.3141.94%0.44220.69%0.350.00%0.33-26.92%0.19-16.00%0.6340.91%0.31-245.00%-0.2965.00%0.33116.67%0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Enerpac Tool
EPAC
46.250
Precision Drilling
PDS
46.950
Workday
WDAY
251.790
4
Halozyme Therapeutics
HALO
64.460
5
Cars.com
CARS
12.340
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Earnings Season Underway
Earnings season is here. What to know?